Thromboembolic events, bleeding, and drug discontinuation in patients with atrial fibrillation on anticoagulation: a prospective hospital-based registry

BACKGROUND: The clinical practice of stroke prevention in atrial fibrillation (AF) with direct oral anticoagulants (DOACS) differs from anticoagulation in randomized trial patients. We investigated the risk of thromboembolism, bleeding, and drug discontinuation in a hospital-based real-world setting...

Descripción completa

Detalles Bibliográficos
Autores principales: Königsbrügge, Oliver, Simon, Alexander, Domanovits, Hans, Pabinger, Ingrid, Ay, Cihan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5148877/
https://www.ncbi.nlm.nih.gov/pubmed/27938343
http://dx.doi.org/10.1186/s12872-016-0438-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5148877/
https://www.ncbi.nlm.nih.gov/pubmed/27938343
http://dx.doi.org/10.1186/s12872-016-0438-5

Ejemplares similares